Financials data is unavailable for this security.
View more
Year on year Lee's Pharmaceutical Holdings Ltd 's revenues fell -14.61% from 1.23bn to 1.05bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 51.28m to 16.70m, a -67.44% decrease.
Gross margin | 51.49% |
---|---|
Net profit margin | 4.50% |
Operating margin | 6.56% |
Return on assets | 1.98% |
---|---|
Return on equity | 3.42% |
Return on investment | 2.52% |
More ▼
Cash flow in HKDView more
In 2023, cash reserves at Lee's Pharmaceutical Holdings Ltd fell by 21.77m. However, the company earned 110.08m from its operations for a Cash Flow Margin of 10.45%. In addition the company generated 13.44m cash from financing while 145.22m was spent on investing.
Cash flow per share | 0.3331 |
---|---|
Price/Cash flow per share | 3.54 |
Book value per share | 2.91 |
---|---|
Tangible book value per share | 1.07 |
More ▼
Balance sheet in HKDView more
Current ratio | 1.10 |
---|---|
Quick ratio | 0.7425 |
Total debt/total equity | 0.1444 |
---|---|
Total debt/total capital | 0.132 |
More ▼
Growth rates in HKD
SmartText is unavailable
Div yield(5 year avg) | 1.35% |
---|---|
Div growth rate (5 year) | -31.34% |
Payout ratio (TTM) | 9.34% |
EPS growth(5 years) | -47.38 |
---|---|
EPS (TTM) vs TTM 1 year ago | 61.94 |
More ▼